Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Traditional Herbal Medicine + Neoadjuvant Therapy in Breast Cancer
NCT05483439Phase 2Unknown
- Sponsor
- Shengjing Hospital of China Medical University
- Start
- Oct 2021
- Primary completion
- Jul 2023
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in breast cancer (2 arms), sponsored by Shengjing Hospital of China Medical University. Primary endpoint: Total Pathological Complete Response Rate. Status: unknown.
02
Conditions
breast cancer
Beyond the preview
Go deeper on NCT05483439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05483439.